Seasoned investor and operator focused on growth-stage technology, healthcare and consumer sectors, combining corporate-development and fundraising expertise with hands-on portfolio work. Isabelle Cordwell-Riant has led deal sourcing, due diligence and board-level value creation for venture and private equity investors, and is known for cross-border transaction experience and operational scaling initiatives. Regularly engages in strategic advisory, capital formation and governance with emphasis on commercializing innovation and driving revenue growth.
Seasoned investor and operator focused on growth-stage technology, healthcare and consumer sectors, combining corporate-development and fundraising expertise with hands-on portfolio work. Isabelle Cordwell-Riant has led deal sourcing, due diligence and board-level value creation for venture and private equity investors, and is known for cross-border transaction experience and operational scaling initiatives. Regularly engages in strategic advisory, capital formation and governance with emphasis on commercializing innovation and driving revenue growth.
Focuses on growth-stage investments across technology, healthcare and consumer sectors, prioritizing companies with validated product-market fit and clear pathways to revenue scale. Favors cross-border opportunities where operational scaling, commercial go-to-market and governance can unlock value. Employs hands-on, board-level engagement and disciplined capital deployment to de-risk growth milestones, balance follow-on allocation with exit timing, and drive revenue-led value creation toward strategic or financial exits.
Focuses on growth-stage investments across technology, healthcare and consumer sectors, prioritizing companies with validated product-market fit and clear pathways to revenue scale. Favors cross-border opportunities where operational scaling, commercial go-to-market and governance can unlock value. Employs hands-on, board-level engagement and disciplined capital deployment to de-risk growth milestones, balance follow-on allocation with exit timing, and drive revenue-led value creation toward strategic or financial exits.
| Trades 886 | Longs Won 530/886 59% | Profit Factor 2.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.34M |
| Average Win $530,488.1 | Best Trade (Jul 13) $21.15M | Sharpe Ratio -10.16 |
| Average Loss -$325,673.2 | Worst Trade (Jul 13) -$9.07M | Z-Score 6.47 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 3w 3d | Expectancy $186,515.79 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,695 | 2,426 | 2,156 | 1,887 | 1,617 | 1,348 | 1,078 | 809 | 539 | 270 |